Metoclopramide may decrease need for second look Endoscopic Visualization in Active Upper GI Bleeding Dr.Niharika Harsha B30 Dec 2023 8:30 AM ISTIn a recent breakthrough study conducted between April 2021 and October 2022, researchers delved into the effectiveness of metoclopramide in improving...
Higher dose of Dexamethasone with metoclopramide may not provide additional relief to migraine patients in ED Dr. Kamal Kant Kohli25 Aug 2023 10:45 AM ISTUSA: A dose of dexamethasone greater than 4mg when added to 10mg IV metoclopramide is unlikely to benefit patients in the emergency department (ED)...
Ondansetron or metoclopramide, which is better for managing hyperemesis gravidarum? Medha Baranwal15 Sept 2022 7:30 PM ISTJordan: Ondansetron and metoclopramide seem to be equally effective for managing hyperemesis gravidarum (HG) among parturient females, says a study...
Prophylactic antiemetics fail to reduce nausea and vomiting induced by IV opioids in ED Dr. Hiral patel27 May 2022 7:45 PM ISTCHICAGO: Prophylactic Metoclopramide (antiemetics) does not reduce the risk of vomiting, nausea, or the need for rescue medication when provided...
IV Magnesium, a potential alternative in the migraine cocktail: Study MD Bureau4 March 2021 10:06 AM ISTMigraine is the second most disabling neurologic condition in the United States, resulting in a $27 billion cost due to loss of productivity. IV...
Metoclopramide inhibits proliferation of leukemia stem cells, finds study Hina Zahid29 Jan 2021 12:16 AM ISTChronic myeloid leukemia (CML) results from a degeneration of the hematopoietic stem cells (leukemia stem cells), thereby leading to the uncontrolled...
GON block with bupivacaine not superior to metoclopramide for migraine treatment: Study Medha Baranwal23 Nov 2020 7:45 PM ISTUSA: Greater occipital nerve blocks (GONB) with bupivacaine is not effective as IV metoclopramide for the first-line migraine treatment in the...
FDA approves metoclopramide nasal spray for diabetic gastroparesis Dr. Kamal Kant Kohli25 Jun 2020 9:30 AM ISTThe Food and Drug Administration has approved a new formulation of metoclopramide(Gomoti) for relief symptoms in adults with acute and recurrent...
